3-(CYCLOPROPYLMETHOXY)-4-METHOXYBENZOIC ACID, 95.0%, 250mg

1-[(Bromoacetyl)oxy]pyrrolidine-2,5-dione, 97.0%, 5g

boc-d-glu(otbu)-oh, 95.0%, 5g

Ethyl5-[[[[3'-(Methylsulfonyl)[1,1'-biphenyl]-4-yl]methyl][(2,4,6-trimethylphenyl)sulfonyl]amino]methyl]-2-furancarboxylate, 98%, 1g

Piperazin-1-yl(pyridin-2-yl)methanone dihydrochloride, 98%, 100g

1-Hexanol, min.98%, pour la synthèse, 2,5 L, emballage en verre

5-BROMO-1-ETHYL-3-IODO-1H-PYRROLO[2,3-C]PYRIDINE, 95.0%, 500mg

(R)-4-Amino-5-(tert-butoxy)-5-oxopentanoic acid, 95.0%, 10g

3,5-Dibromo-4-chloropyridine, 95.0%, 100g

Systèmes de dialyse Spectra/Por® Float-A-Lyzer® G2 Volume de remplissage 10 ml, 500–1000 dalton(s), 12 pièce(s)

4,5-Dibromo-N-methoxy-N-methylfuran-2-carboxamide, 95+%, 1g

(2-Bromo-1-fluoroethyl)benzene, 95.0%, 100mg

3-piperidin-2-ylpropan-1-ol, 95.0%, 10g